October 1, 2014
New Findings on How Glatiramer Acetate Works for Multiple Sclerosis
- /
By Gale Scott | September 29, 2014 Patients with the relapsing-remitting (RRMS) form of multiple sclerosis (MS) have shown improvement with…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
October 1, 2014
159 Genetic Variants Now Known to Be Associated With MS
- /
- /
The International MS Genetics consortium recently identified more than 45 new genetic variants associated with susceptibility to multiple sclerosis, many…
October 1, 2014
What’s the Role of Myelin Oligodendrocyte Glycoprotein in NMO (NeuroMyelitis Optica)?
- /
Researchers are working to refine a cell-based assay that more accurately identifies antibodies for myelin oligodendrocyte glycoprotein (MOG) in the…
October 1, 2014
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis (TERIKIDS)
- /
- /
Purpose Primary Objective: To assess the effect of teriflunomide in comparison to placebo on disease activity measured by time…
October 1, 2014
Study Finds Link Between MS and Schizophrenia Risk
- /
Analyzing a large medical database, researchers have found that patients with MS have an increased risk of bipolar disorder. Researchers…
October 1, 2014
Pilot Study Finds Stem Cell Treatment Safe for MS Patients
- /
- /
Source: MSFYI newsletter – August 2014 Researchers found that stem cell transplantation may be safe and feasible for MS patients.…
September 30, 2014
Multiple Sclerosis Patients Successfully Replace Damaged Cells With New Healthy Stem Cells; First Treatment With Placenta
- /
- /
- /
Multiple sclerosis patients show improvement when damaged cells are replaced with placenta.Photo courtesy of Shutterstock Sept 29, 2014 Multiple sclerosis is…
September 29, 2014
Secondary Progressive Multiple Sclerosis (SPMS) in Australia
- /
The MIS416 trial is a clinical research trial now enrolling patients with Secondary Progressive Multiple Sclerosis (SPMS) in Australia. Full…
September 29, 2014
Orphan Drug Designation Granted to Treatment for Rare Multiple Sclerosis Drug Complication known as PML
- /
The Food and Drug Administration granted Orphan Drug Designation to Inhibikase Therapeutics’, Inc. lead product, IkT-001Pro (imatinib), to treat progressive multifocal leukoencephalopathy (PML). According…
September 29, 2014
Low Dose Naltrexone May Improve Multiple Sclerosis Patient Quality of Life
- /
- /
Low dose naltrexone (LDN) may be on its way to becoming a new therapeutic agent for multiple sclerosis. Evidence for its efficacy…
